Cooper Companies Inc

COO · Health Technology · Medical Specialties · US

15,000 employees · coopercos.com

About

CooperVision, a division of The Cooper Cos, Inc., generates revenue through the sale of soft contact lenses including single-use, two-week, and monthly options across spherical, aspherical, toric, and multifocal varieties. These products are distributed globally in the Americas, EMEA, and Asia Pacific regions, manufactured at facilities in the UK, Puerto Rico, Hungary, Costa Rica, and New York. CooperSurgical, the other business unit, provides women's health, fertility, and diagnostic solutions, serving healthcare providers and institutions focused on family health advancement. The company's revenue streams are derived from direct sales to eye care professionals and healthcare institutions purchasing these specialized medical devices and services.

Annual results

Reported figures, USD · revenue up 5.1% in 2025

YearRevenueNet incomeNet marginFree cash flow
20254.1B374M9.1%434M
20243.9B392M10.1%288M
20233.6B294M8.2%215M
20223.3B385M11.6%450M
20212.9B2.9B100.8%524M

Dividends per share

2023 0.01 USD2022 0.01 USD2021 0.01 USD2020 0.01 USD2019 0.01 USD

COO in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Cooper Companies Inc are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Cooper Companies Inc (COO) — company profile and financials · MarketPulse